SAVVY Vaginal Gel (C31G) for Prevention of HIV Infection: A Randomized Controlled Trial in Nigeria

Paul J. Feldblum, Adesina Adeiga, Rashidi Bakare et al. · 2008

Read SAVVY Vaginal Gel (C31G) for Prevention of HIV Infection: A Randomized Controlled Trial in Nigeria by Paul J. Feldblum, Adesina Adeiga, Rashidi Bakare et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001474.txt.

Description

Paul Feldblum and colleagues published a 2008 PLOS ONE trial report on a gel meant to block HIV in Nigeria. The gel, called SAVVY, was used in the vagina before sex. The trial enrolled women at high risk of HIV. It was a large phase 3 trial, with women split at random to gel or a dummy gel.

Women were followed for up to twelve months with regular HIV tests. The team weighed whether the gel cut new infections in real use. Gel based guards would give women a method they control themselves. Each such trial, win or lose, shapes the search for a workable guard.

Catalog record

CREATORPaul J. Feldblum, Adesina Adeiga, Rashidi Bakare et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001474

Browse the full library · About the Tower of Babel